Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Clamps Down On Chemical Firm Drug Ingredients

This article was originally published in PharmAsia News

Executive Summary

China plans to have in place by the end of this year a new system to control ingredients used in pharmaceuticals. The State FDA says it will focus on ingredients made by chemical firms for the medicine market along with higher production standards. The stricter controls are a response, in part, to complaints of contaminated and other problem goods produced in China for foreign markets. The SFDA and other agencies also plan to keep a closer eye on chemical firms that seek to move into the pharmaceutical market. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts